Overview

Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate

Status:
Completed

Trial end date:
2018-07-20

Target enrollment:

Participant gender:

Summary

This study is planned to explore the effect of food on the oral pharmacokinetics, the intravenous pharmacokinetics and the absolute bioavailability of BAY1834845. Furthermore, this study will investigate the effect of BAY1834845 on the pharmacokinetics of orally administered methotrexate in healthy male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Methotrexate